INR 20.96
(-4.86%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5059.00 INR | 107.76% |
2022 | 2435.00 INR | -46.61% |
2021 | 4561.00 INR | 36.75% |
2020 | 3335.37 INR | 17.63% |
2019 | 2835.37 INR | 89.02% |
2018 | 1500.00 INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | 0.0% |
2013 | - INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q4 | 5058.60 INR | 0.0% |
2023 FY | 5058.60 INR | 107.75% |
2023 Q1 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 2435.00 INR | 0.0% |
2022 Q2 | 5211.00 INR | 0.0% |
2021 Q2 | 4135.00 INR | 0.0% |
2021 Q4 | 4561.00 INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 Q4 | 3335.37 INR | 0.0% |
2020 Q2 | 3335.00 INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 2835.37 INR | 0.0% |
2019 Q2 | 2000.00 INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q3 | - INR | 0.0% |
2018 Q4 | 1500.00 INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2017 Q3 | - INR | 0.0% |
2017 Q2 | - INR | 0.0% |
2017 Q1 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2016 Q2 | 200.00 INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | - INR | 0.0% |
2016 Q1 | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2015 Q2 | 300.00 INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q3 | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2014 Q1 | - INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2013 Q2 | 100.00 INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | - INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.35 Billion INR | 100.0% |
Biocon Limited | 162.76 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 16.12 Million INR | 99.969% |
Concord Biotech Limited | 97.37 Million INR | 99.995% |
Dishman Carbogen Amcis Limited | 23.12 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
Lyka Labs Limited | 586.5 Million INR | 99.999% |
Panacea Biotec Limited | 209.9 Million INR | 99.998% |
SAMSRITA LABS LIMITED | 22.03 Million INR | 99.977% |
SMS Lifesciences India Limited | 1 Billion INR | 99.999% |
Supriya Lifescience Limited | 54.88 Million INR | 99.991% |
Syngene International Limited | 5.55 Billion INR | 100.0% |
TAKE Solutions Limited | 370.85 Million INR | 99.999% |
Titan Biotech Limited | 83.02 Million INR | 99.994% |
Transgene Biotek Limited | 140.01 Million INR | 99.996% |
Vanta Bioscience Limited | 609.53 Million INR | 99.999% |